763 related articles for article (PubMed ID: 30040735)
1. Diffuse Amyloid-β Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons' Brains Lacking Neuritic Amyloid Plaques.
Abner EL; Neltner JH; Jicha GA; Patel E; Anderson SL; Wilcock DM; Van Eldik LJ; Nelson PT
J Alzheimers Dis; 2018; 64(4):1307-1324. PubMed ID: 30040735
[TBL] [Abstract][Full Text] [Related]
2. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
3. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
[TBL] [Abstract][Full Text] [Related]
4. Relationship between apolipoprotein E and the amyloid deposits and dystrophic neurites of Alzheimer's disease.
Dickson TC; Saunders HL; Vickers JC
Neuropathol Appl Neurobiol; 1997 Dec; 23(6):483-91. PubMed ID: 9460714
[TBL] [Abstract][Full Text] [Related]
5. The spectrum of preclinical Alzheimer's disease pathology and its modulation by ApoE genotype.
Pletnikova O; Kageyama Y; Rudow G; LaClair KD; Albert M; Crain BJ; Tian J; Fowler D; Troncoso JC
Neurobiol Aging; 2018 Nov; 71():72-80. PubMed ID: 30099348
[TBL] [Abstract][Full Text] [Related]
6. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
[TBL] [Abstract][Full Text] [Related]
7. Oligomeric Abeta in Alzheimer's disease: relationship to plaque and tangle pathology, APOE genotype and cerebral amyloid angiopathy.
van Helmond Z; Miners JS; Kehoe PG; Love S
Brain Pathol; 2010 Mar; 20(2):468-80. PubMed ID: 19725829
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
[TBL] [Abstract][Full Text] [Related]
9. Sequence of Abeta-protein deposition in the human medial temporal lobe.
Thal DR; Rüb U; Schultz C; Sassin I; Ghebremedhin E; Del Tredici K; Braak E; Braak H
J Neuropathol Exp Neurol; 2000 Aug; 59(8):733-48. PubMed ID: 10952063
[TBL] [Abstract][Full Text] [Related]
10. Amyloid beta protein deposition in patients with frontotemporal lobar degeneration: relationship to age and apolipoprotein E genotype.
Mann DM; McDonagh AM; Pickering-Brown SM; Kowa H; Iwatsubo T
Neurosci Lett; 2001 May; 304(3):161-4. PubMed ID: 11343827
[TBL] [Abstract][Full Text] [Related]
11. Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer's disease brains: Implications for in-vivo diagnostics.
den Haan J; Morrema THJ; Rozemuller AJ; Bouwman FH; Hoozemans JJM
Acta Neuropathol Commun; 2018 Aug; 6(1):75. PubMed ID: 30092839
[TBL] [Abstract][Full Text] [Related]
12. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
[TBL] [Abstract][Full Text] [Related]
13. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau.
Hohman TJ; Dumitrescu L; Barnes LL; Thambisetty M; Beecham G; Kunkle B; Gifford KA; Bush WS; Chibnik LB; Mukherjee S; De Jager PL; Kukull W; Crane PK; Resnick SM; Keene CD; Montine TJ; Schellenberg GD; Haines JL; Zetterberg H; Blennow K; Larson EB; Johnson SC; Albert M; Bennett DA; Schneider JA; Jefferson AL;
JAMA Neurol; 2018 Aug; 75(8):989-998. PubMed ID: 29801024
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer beta amyloid deposition enhanced by apoE epsilon4 gene precedes neurofibrillary pathology in the frontal association cortex of nondemented senior subjects.
Yamaguchi H; Sugihara S; Ogawa A; Oshima N; Ihara Y
J Neuropathol Exp Neurol; 2001 Jul; 60(7):731-9. PubMed ID: 11444802
[TBL] [Abstract][Full Text] [Related]
15. Neuropathology of cognitively normal elderly.
Knopman DS; Parisi JE; Salviati A; Floriach-Robert M; Boeve BF; Ivnik RJ; Smith GE; Dickson DW; Johnson KA; Petersen LE; McDonald WC; Braak H; Petersen RC
J Neuropathol Exp Neurol; 2003 Nov; 62(11):1087-95. PubMed ID: 14656067
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E4 promotes the early deposition of Abeta42 and then Abeta40 in the elderly.
Walker LC; Pahnke J; Madauss M; Vogelgesang S; Pahnke A; Herbst EW; Stausske D; Walther R; Kessler C; Warzok RW
Acta Neuropathol; 2000 Jul; 100(1):36-42. PubMed ID: 10912918
[TBL] [Abstract][Full Text] [Related]
17. Associations of regional amyloid-β plaque and phospho-tau pathology with biological factors and neuropsychological functioning among HIV-infected adults.
Soontornniyomkij V; Moore DJ; Gouaux B; Soontornniyomkij B; Sinsheimer JS; Levine AJ
J Neurovirol; 2019 Dec; 25(6):741-753. PubMed ID: 31144289
[TBL] [Abstract][Full Text] [Related]
18. Disentangling the effects of age and APOE on neuropathology and late life cognitive decline.
Yu L; Boyle PA; Leurgans S; Schneider JA; Bennett DA
Neurobiol Aging; 2014 Apr; 35(4):819-26. PubMed ID: 24199961
[TBL] [Abstract][Full Text] [Related]
19. A 2-process model for neuropathology of Alzheimer's disease.
Mungas D; Tractenberg R; Schneider JA; Crane PK; Bennett DA
Neurobiol Aging; 2014 Feb; 35(2):301-8. PubMed ID: 24080173
[TBL] [Abstract][Full Text] [Related]
20. Levels of Retinal Amyloid-β Correlate with Levels of Retinal IAPP and Hippocampal Amyloid-β in Neuropathologically Evaluated Individuals.
Schultz N; Byman E; ; Wennström M
J Alzheimers Dis; 2020; 73(3):1201-1209. PubMed ID: 31884473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
